OncologyTube.com is the first and only free video sharing website dedicated to helping oncology professionals spread knowledge about cancer research through video, audio and other multimedia.
    • OncologyTube Cancer Articles, News and Videos

      Site: OncologyTube Cancer Articles, News and Videos

    • Products & Pricing
      • Banner Advertising Plans
      • eNewsletter Packages
      • Pre-Roll Advertising
      • Create A Deep Dive Conversation
      • Create a Video Release (VR)
      • Boost Earned Media Only $60
    • 0
      • Portuguese
      • Spanish
      • Italian
      • Greek (Greece)
      • Sinhala
      • Polish
      • Arabic (Saudi Arabia)
      • Swedish (Sweden)
      • Portuguese (Brazil)
      • Hindi (India)
      • English (Australia)
      • Hebrew (Israel)
      • Czech
      • Hungarian (Hungary)
      • Chinese
      • Turkish
      • Japanese (Japan)
      • Dutch
      • French
      • German
      • Chinese (Traditional Han, Taiwan)
      • Korean (South Korea)
      • Thai
      • Spanish (Chile)
      • English (United States)
      • Russian
      • Danish (Denmark)
  • Home
  • Trending

  • Login

  • Quick Links
  • How To Self Record An Interview and Presentations
  • Schedule A Remote Interview!
  • Check Out Our Blog
  • Buy Advertising Banners
  • Buy Pre-Roll Advertisements
  • Boost Your Earned Media starting at Just $60
  • Create A Deep Dive Conversation
  • Advertising Specifications
  • Our Editorial Process
  • Publisher Calendar

  • Mobile
  • Connect Mobile App

  • Audio and Video
  • Videos
  • Audio

  • Channels
  • Browse Channels

  • Categories
  • Acute Lymphoblastic Leukemia 5595
  • Acute Myelogenous Leukemia 226
  • Bladder 96
  • Bone Metastases 5
  • Brain 79
  • Breast 548
  • Business Management 5
  • Cervical 16
  • Chronic Lymphocytic Leukemia 209
  • Chronic Myelogenous Leukemia 54
  • Colorectal 172
  • Conference Coverage 1
  • COVID-19 43
  • Gastrointestinal 177
  • General 341
  • Genitourinary 3
  • Head and Neck 110
  • Help 3
  • Hematologic Malignancies 206
  • Hodgkin Lymphoma 34
  • Imaging 2
  • Immunotherapy 179
  • Kidney 392
  • Liver 40
  • Lung 95
  • Lymphoma 235
  • Melanoma and Skin 107
  • Multiple Myeloma 535
  • Myeloproliferative Disease 37
  • News 149
  • Non-Hodgkin Lymphoma 81
  • Non-Small Cell Lung Cancer 554
  • Other 517
  • Ovarian 65
  • Pancreatic 102
  • Patient Resources 51
  • Pediatric 7
  • Prostate 300
  • Sarcoma 13
  • Sickle Cell 22
  • Small Cell Lung Cancer 81
  • Supportive Care 51
  • Testicular 3
  • Urology 16
  • Uterine 9

  • Install
  • Play a Link
  • About
  • Contact
  • Acute Lymphoblastic Leukemia
  • Acute Myelogenous Leukemia
  • Bladder
  • Bone Metastases
  • Brain
  • Breast
  • Business Management
  • Cervical
  • Chronic Lymphocytic Leukemia
  • Chronic Myelogenous Leukemia
  • Colorectal
  • Conference Coverage
  • COVID-19
  • Gastrointestinal
  • General
  • Genitourinary
  • Head and Neck
  • Help
  • Hematologic Malignancies
  • Hodgkin Lymphoma
  • Imaging
  • Immunotherapy
  • Kidney
  • Liver
  • Lung
  • Lymphoma
  • Melanoma and Skin
  • Multiple Myeloma
  • Myeloproliferative Disease
  • News
  • Non-Hodgkin Lymphoma
  • Non-Small Cell Lung Cancer
  • Other
  • Ovarian
  • Pancreatic
  • Patient Resources
  • Pediatric
  • Prostate
  • Sarcoma
  • Sickle Cell
  • Small Cell Lung Cancer
  • Supportive Care
  • Testicular
  • Urology
  • Uterine
Researchers Find Common Measures of Immune Status, Inflammation Can Predict Mortality

Researchers Find Common Measures of Immune Status, Inflam...

A new collaborative study led by Cleveland Clinic and University Hospitals has found that commonly used clinical indicators of immune status and inflammation can predict mortality in the general population.

Published in JAMA Network Open, the study showed that lymphopenia (a condition characterized by low levels of a specific type of white blood cell, called lymphocytes) is associated with death due to heart disease, cancer and respiratory infections, including influenza and pneumonia. This relationship between lymphocyte levels and mortality was observed independent of age, other blood-based immune markers and clinical risk factors.

 

The research team was led by David Zidar, M.D., Ph.D., an interventional cardiologist and immunologist at UH Cleveland Medical Center and the Louis Stokes Cleveland Veteran Affairs Medical Center and Assistant Professor of Medicine at Case Western Reserve University School of Medicine, and Jarrod Dalton, Ph.D., epidemiologist in Cleveland Clinic’s Lerner Research Institute.

“Scientists have gone to great lengths and expense to develop novel biomarkers to identify people at the highest risk for death and disease,” said Dalton, senior author on the study. “Here we have taken a more pragmatic approach – investigating the predictive power of components of a patient’s white blood cell count, which is collected as part of routine blood work during standard health exams. The complete blood count test is convenient, inexpensive and, as our findings suggest, may be used to help physicians screen for and prevent disease and disease-related mortality.”

In this study, the team analyzed data from more than 31,000 participants who were followed over the course of 12 years as part of the National Health and Examination Survey (NHANES). NHANES is a program of the National Center for Health Statistics, part of the Centers for Disease Control and Prevention. Study participants were representative of the general United States adult population.

While the association between lymphopenia and reduced survival was observed independent of age and traditional clinical risk factors, the strength of the association increased when low lymphocyte levels presented in combination with other blood abnormalities, including elevated red blood cell distribution width (a measure of the body’s ability to generate and maintain a healthy population of red blood cells) and levels of C-reactive protein (an indicator of inflammation).

Applied in practice, the study’s findings suggest, for example, that a 65-year old with a high-risk profile based on these three immune indicators – lymphocyte count, red blood cell distribution width and C-reactive protein levels – is actually at greater mortality risk than someone who is a decade older and has a low-risk profile.

“With additional research, we will soon begin to understand the biologic processes that link these markers to disease, a critical step in the search for therapeutic targets,” said Sadeer Al-Kindi, M.D., a cardiologist at University Hospitals, clinical instructor at Case Western Reserve University School of Medicine and co-author on the study. “More immediately, we can certainly design systems that allow physicians to use pragmatic immune status indicators to ensure that the 10-20% of the general population at highest risk for mortality do not fall through the cracks of routine preventive care and early detection services.”

This study was a collaboration between members of the Clinical and Translational Science Collaborative (CTSC) of Cleveland, including researchers from Cleveland Clinic, University Hospitals, Case Western Reserve University, Louis Stokes Cleveland Veterans Affairs Medical Center and MetroHealth Medical Center. The CTSC Awards Program is administered through the National Center for Advancing Translational Sciences, part of the National Institutes of Health (NIH). This study was also supported by the National Institute of Aging, of the NIH.

 

 

0?ui=2&ik=834f2e870a&attid=0.1&permmsgid=msg-f:1651372243630056338&th=16eada4e65826392&view=fimg&sz=s0-l75-ft&attbid=ANGjdJ-n3ECD-RbBRG_XfTrjz8tAjrepBAIQXAHEdFE-wjsamCZVjDv-mQZaZX29sOsoipTiVYgG1YkR-wc-F7RLliDxVaF2g8ptzrUs8e2fUI3NuIinKMxx19jAOUs&disp=emb


Alicia Reale Cooney  |  Sr. Manager  |  Corporate Communications  |  Cleveland Clinic

9500 Euclid Ave. JJN4-01  |  Cleveland, OH 44195  | (216) 445-8324 |  (216) 408-7444 cell

0?ui=2&ik=834f2e870a&attid=0.2&permmsgid=msg-f:1651372243630056338&th=16eada4e65826392&view=fimg&sz=s0-l75-ft&attbid=ANGjdJ-oCs7A-fLZmGqP0drkY91iO136AYvZELYbV0RH0q0o8yEsve4BdZRra1oO0N8vWb8659y44xTkAxPV5DWPa9pthChu1wougwcPLbjGssKw5o1X1MWJ63HksnA&disp=emb   0?ui=2&ik=834f2e870a&attid=0.3&permmsgid=msg-f:1651372243630056338&th=16eada4e65826392&view=fimg&sz=s0-l75-ft&attbid=ANGjdJ9rCEzSJIoWM4YN5PDOJEC1TSgXPtydypmuaIbKM3qRURTrmRDBMIO062RrUAjnuBlNPAoNGApp_YaG95clPi9RVh-x4WKQCleHEHoCHHTLr_43FXt4M112Emw&disp=emb 0?ui=2&ik=834f2e870a&attid=0.4&permmsgid=msg-f:1651372243630056338&th=16eada4e65826392&view=fimg&sz=s0-l75-ft&attbid=ANGjdJ_B2Tbasi7d9THeV2rVuVC8L6dc_nIH4r6mqwnG4ZKV5qruwp8dFcbyYTNL7DQgqh6-l0G8-sE_sott3RAQygFGswym5XeJg6BGlaCe7OurSebhnOp4y7NBEmg&disp=emb0?ui=2&ik=834f2e870a&attid=0.5&permmsgid=msg-f:1651372243630056338&th=16eada4e65826392&view=fimg&sz=s0-l75-ft&attbid=ANGjdJ8L_wjJbAsUQ6e2cPmGzI1rqHXhAyxWLj_cktrZ7ddflVurzrFZevCANJiLdxkfh2paoKctiaWjCG6YnXPAiQTaMUkSivdydbu1HKHSx-s9tCx4JnucsIcqGZw&disp=emb

 

 

 

Please consider the environment before printing this e-mail

Cleveland Clinic is currently ranked as one of the nation’s top hospitals by U.S. News & World Report (2019-2020). Visit us online at http://www.clevelandclinic.org for a complete listing of our services, staff and locations. Confidentiality Note: This message is intended for use only by the individual or entity to which it is addressed and may contain information that is privileged, confidential, and exempt from disclosure under applicable law. If the reader of this message is not the intended recipient or the employee or agent responsible for delivering the message to the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this communication in error, please contact the sender immediately and destroy the material in its entirety, whether electronic or hard copy. Thank you.

47 Views
3 years Ago
Cleveland Clinic
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

News

Martin S. Tallman, MD @MartinTallman @sloan_kettering @WeillCornell #ASHPresident21 #ASH #Cancer #Research Begins Term as 2021 ASH President
00:05:40
Martin S. Tallman, MD @MartinTallman @sloan_kettering @We...
17 Views
2 years Ago
Cancer News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Mallinckrodt Receives Approval in Japan of the CELLEX® Extracorporeal Photopheresis System for Treatment of Chronic Graft Versus Host Disease
Mallinckrodt Receives Approval in Japan of the CELLEX® E...
12 Views
2 years Ago
Cancer
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Study Findings: DNA that Pinpoint Risks for Cancers - Benjamin Tycko, MD @HMHNewJersey
0:04:12
Study Findings: DNA that Pinpoint Risks for Cancers - Ben...
29 Views
2 years Ago
Cancer
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Classical Cancer Epigenetic vs Epigenetic Mapping - Benjamin Tycko, MD @HMHNewJersey
0:02:20
Classical Cancer Epigenetic vs Epigenetic Mapping - Benja...
27 Views
2 years Ago
Cancer
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Signposts in DNA that Pinpoint Risks for Cancers and other Diseases - Benjamin Tycko, MD @HMHNewJersey
0:17:12
Signposts in DNA that Pinpoint Risks for Cancers and othe...
23 Views
2 years Ago
Cancer
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
J. Marie Suga MD on Benefits in Implementing a Genomic Oncology Program #ASCO2020 #ASCO @jmsuga
0:02:39
J. Marie Suga MD on Benefits in Implementing a Genomic On...
11 Views
2 years Ago
Cancer
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
J. Marie Suga MD on Implementing a Genomic Oncology Program: What Are The Barriers? #ASCO2020 #ASCO @jmsuga
0:04:32
J. Marie Suga MD on Implementing a Genomic Oncology Progr...
21 Views
2 years Ago
Cancer
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
J. Marie Suga MD on Implementing a Genomic Oncology Program  #ASCO2020 #ASCO @jmsuga
0:08:23
J. Marie Suga MD on Implementing a Genomic Oncology Progr...
61 Views
2 years Ago
Cancer
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Oncocyte announces launch of CLIA-Validated DetermaIO™
Oncocyte announces launch of CLIA-Validated DetermaIO™
59 Views
3 years Ago
Cancer
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19
Mount Sinai and Harbour BioMed Collaborate to Advance Nov...
28 Views
3 years Ago
Cancer
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
NCCN 2020 Annual Conference to Examine Advances in Cancer Care and Emerging Issues in Oncology
NCCN 2020 Annual Conference to Examine Advances in Cancer...
28 Views
3 years Ago
Cancer
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
THE FIRST PATIENT INCLUDED IN JAPAN IN ISOFOL’S PHASE 3 AGENT STUDY
THE FIRST PATIENT INCLUDED IN JAPAN IN ISOFOL’S PHASE 3...
18 Views
3 years Ago
Cancer
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

comments@oncologytube.com Copyright 2023 Medicus Networks, Inc. 45121 Morgan Heights Rd. Temecula, CA 92592